The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mycophenolate Mofetil Market Research Report 2024
Synopsis
Mycophenolate Mofetil drug in this report.
The global Mycophenolate Mofetil market was valued at US$ 674 million in 2023 and is anticipated to reach US$ 962.1 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
North American market for Mycophenolate Mofetil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mycophenolate Mofetil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Mycophenolate Mofetil include Genentech, Teva, Sandoz, West Ward Pharmaceuticals, Accord Healthcare, Mylan, Strides Pharma, Jubilant Cadista and Alkem Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mycophenolate Mofetil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycophenolate Mofetil.
Report Scope
The Mycophenolate Mofetil market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mycophenolate Mofetil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycophenolate Mofetil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genentech
Teva
Sandoz
West Ward Pharmaceuticals
Accord Healthcare
Mylan
Strides Pharma
Jubilant Cadista
Alkem Laboratories
Akorn
Passauer Pharma GmbH
Par Pharmaceutical
Segment by Type
Capsule
Tablet
Injection
Segment by Application
Heart Transplant
Liver Transplant
Kidney Transplant
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mycophenolate Mofetil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mycophenolate Mofetil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Mycophenolate Mofetil drug in this report.
The global Mycophenolate Mofetil market was valued at US$ 674 million in 2023 and is anticipated to reach US$ 962.1 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
North American market for Mycophenolate Mofetil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mycophenolate Mofetil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Mycophenolate Mofetil include Genentech, Teva, Sandoz, West Ward Pharmaceuticals, Accord Healthcare, Mylan, Strides Pharma, Jubilant Cadista and Alkem Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Mycophenolate Mofetil, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycophenolate Mofetil.
Report Scope
The Mycophenolate Mofetil market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mycophenolate Mofetil market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mycophenolate Mofetil manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Genentech
Teva
Sandoz
West Ward Pharmaceuticals
Accord Healthcare
Mylan
Strides Pharma
Jubilant Cadista
Alkem Laboratories
Akorn
Passauer Pharma GmbH
Par Pharmaceutical
Segment by Type
Capsule
Tablet
Injection
Segment by Application
Heart Transplant
Liver Transplant
Kidney Transplant
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mycophenolate Mofetil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mycophenolate Mofetil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Mycophenolate Mofetil Market Overview
1.1 Product Overview and Scope of Mycophenolate Mofetil
1.2 Mycophenolate Mofetil Segment by Type
1.2.1 Global Mycophenolate Mofetil Market Value Comparison by Type (2024-2030)
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Injection
1.3 Mycophenolate Mofetil Segment by Application
1.3.1 Global Mycophenolate Mofetil Market Value by Application: (2024-2030)
1.3.2 Heart Transplant
1.3.3 Liver Transplant
1.3.4 Kidney Transplant
1.4 Global Mycophenolate Mofetil Market Size Estimates and Forecasts
1.4.1 Global Mycophenolate Mofetil Revenue 2019-2030
1.4.2 Global Mycophenolate Mofetil Sales 2019-2030
1.4.3 Global Mycophenolate Mofetil Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mycophenolate Mofetil Market Competition by Manufacturers
2.1 Global Mycophenolate Mofetil Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mycophenolate Mofetil Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mycophenolate Mofetil Average Price by Manufacturers (2019-2024)
2.4 Global Mycophenolate Mofetil Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mycophenolate Mofetil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mycophenolate Mofetil, Product Type & Application
2.7 Mycophenolate Mofetil Market Competitive Situation and Trends
2.7.1 Mycophenolate Mofetil Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mycophenolate Mofetil Players Market Share by Revenue
2.7.3 Global Mycophenolate Mofetil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mycophenolate Mofetil Retrospective Market Scenario by Region
3.1 Global Mycophenolate Mofetil Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mycophenolate Mofetil Global Mycophenolate Mofetil Sales by Region: 2019-2030
3.2.1 Global Mycophenolate Mofetil Sales by Region: 2019-2024
3.2.2 Global Mycophenolate Mofetil Sales by Region: 2025-2030
3.3 Global Mycophenolate Mofetil Global Mycophenolate Mofetil Revenue by Region: 2019-2030
3.3.1 Global Mycophenolate Mofetil Revenue by Region: 2019-2024
3.3.2 Global Mycophenolate Mofetil Revenue by Region: 2025-2030
3.4 North America Mycophenolate Mofetil Market Facts & Figures by Country
3.4.1 North America Mycophenolate Mofetil Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mycophenolate Mofetil Sales by Country (2019-2030)
3.4.3 North America Mycophenolate Mofetil Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mycophenolate Mofetil Market Facts & Figures by Country
3.5.1 Europe Mycophenolate Mofetil Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mycophenolate Mofetil Sales by Country (2019-2030)
3.5.3 Europe Mycophenolate Mofetil Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mycophenolate Mofetil Market Facts & Figures by Country
3.6.1 Asia Pacific Mycophenolate Mofetil Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mycophenolate Mofetil Sales by Country (2019-2030)
3.6.3 Asia Pacific Mycophenolate Mofetil Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mycophenolate Mofetil Market Facts & Figures by Country
3.7.1 Latin America Mycophenolate Mofetil Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mycophenolate Mofetil Sales by Country (2019-2030)
3.7.3 Latin America Mycophenolate Mofetil Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mycophenolate Mofetil Market Facts & Figures by Country
3.8.1 Middle East and Africa Mycophenolate Mofetil Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mycophenolate Mofetil Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mycophenolate Mofetil Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mycophenolate Mofetil Sales by Type (2019-2030)
4.1.1 Global Mycophenolate Mofetil Sales by Type (2019-2024)
4.1.2 Global Mycophenolate Mofetil Sales by Type (2025-2030)
4.1.3 Global Mycophenolate Mofetil Sales Market Share by Type (2019-2030)
4.2 Global Mycophenolate Mofetil Revenue by Type (2019-2030)
4.2.1 Global Mycophenolate Mofetil Revenue by Type (2019-2024)
4.2.2 Global Mycophenolate Mofetil Revenue by Type (2025-2030)
4.2.3 Global Mycophenolate Mofetil Revenue Market Share by Type (2019-2030)
4.3 Global Mycophenolate Mofetil Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mycophenolate Mofetil Sales by Application (2019-2030)
5.1.1 Global Mycophenolate Mofetil Sales by Application (2019-2024)
5.1.2 Global Mycophenolate Mofetil Sales by Application (2025-2030)
5.1.3 Global Mycophenolate Mofetil Sales Market Share by Application (2019-2030)
5.2 Global Mycophenolate Mofetil Revenue by Application (2019-2030)
5.2.1 Global Mycophenolate Mofetil Revenue by Application (2019-2024)
5.2.2 Global Mycophenolate Mofetil Revenue by Application (2025-2030)
5.2.3 Global Mycophenolate Mofetil Revenue Market Share by Application (2019-2030)
5.3 Global Mycophenolate Mofetil Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Genentech
6.1.1 Genentech Corporation Information
6.1.2 Genentech Description and Business Overview
6.1.3 Genentech Mycophenolate Mofetil Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Genentech Mycophenolate Mofetil Product Portfolio
6.1.5 Genentech Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Mycophenolate Mofetil Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Mycophenolate Mofetil Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Mycophenolate Mofetil Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sandoz Mycophenolate Mofetil Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 West Ward Pharmaceuticals
6.4.1 West Ward Pharmaceuticals Corporation Information
6.4.2 West Ward Pharmaceuticals Description and Business Overview
6.4.3 West Ward Pharmaceuticals Mycophenolate Mofetil Sales, Revenue and Gross Margin (2019-2024)
6.4.4 West Ward Pharmaceuticals Mycophenolate Mofetil Product Portfolio
6.4.5 West Ward Pharmaceuticals Recent Developments/Updates
6.5 Accord Healthcare
6.5.1 Accord Healthcare Corporation Information
6.5.2 Accord Healthcare Description and Business Overview
6.5.3 Accord Healthcare Mycophenolate Mofetil Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Accord Healthcare Mycophenolate Mofetil Product Portfolio
6.5.5 Accord Healthcare Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Mycophenolate Mofetil Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Mycophenolate Mofetil Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Strides Pharma
6.6.1 Strides Pharma Corporation Information
6.6.2 Strides Pharma Description and Business Overview
6.6.3 Strides Pharma Mycophenolate Mofetil Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Strides Pharma Mycophenolate Mofetil Product Portfolio
6.7.5 Strides Pharma Recent Developments/Updates
6.8 Jubilant Cadista
6.8.1 Jubilant Cadista Corporation Information
6.8.2 Jubilant Cadista Description and Business Overview
6.8.3 Jubilant Cadista Mycophenolate Mofetil Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Jubilant Cadista Mycophenolate Mofetil Product Portfolio
6.8.5 Jubilant Cadista Recent Developments/Updates
6.9 Alkem Laboratories
6.9.1 Alkem Laboratories Corporation Information
6.9.2 Alkem Laboratories Description and Business Overview
6.9.3 Alkem Laboratories Mycophenolate Mofetil Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Alkem Laboratories Mycophenolate Mofetil Product Portfolio
6.9.5 Alkem Laboratories Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Mycophenolate Mofetil Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Akorn Mycophenolate Mofetil Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 Passauer Pharma GmbH
6.11.1 Passauer Pharma GmbH Corporation Information
6.11.2 Passauer Pharma GmbH Mycophenolate Mofetil Description and Business Overview
6.11.3 Passauer Pharma GmbH Mycophenolate Mofetil Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Passauer Pharma GmbH Mycophenolate Mofetil Product Portfolio
6.11.5 Passauer Pharma GmbH Recent Developments/Updates
6.12 Par Pharmaceutical
6.12.1 Par Pharmaceutical Corporation Information
6.12.2 Par Pharmaceutical Mycophenolate Mofetil Description and Business Overview
6.12.3 Par Pharmaceutical Mycophenolate Mofetil Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Par Pharmaceutical Mycophenolate Mofetil Product Portfolio
6.12.5 Par Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mycophenolate Mofetil Industry Chain Analysis
7.2 Mycophenolate Mofetil Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mycophenolate Mofetil Production Mode & Process
7.4 Mycophenolate Mofetil Sales and Marketing
7.4.1 Mycophenolate Mofetil Sales Channels
7.4.2 Mycophenolate Mofetil Distributors
7.5 Mycophenolate Mofetil Customers
8 Mycophenolate Mofetil Market Dynamics
8.1 Mycophenolate Mofetil Industry Trends
8.2 Mycophenolate Mofetil Market Drivers
8.3 Mycophenolate Mofetil Market Challenges
8.4 Mycophenolate Mofetil Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
